Featured news from NHIVNA

HIV-related news from NAM

New EACS treatment guidelines
Keith Alcorn, 2017-10-26 17:20:00

Everyone with HIV and HCV co-infection should receive direct-acting antiviral treatment for hepatitis C and should receive the same treatment for hepatitis C as people with hepatitis C monoinfection, new European guidelines issued at the 16th European AIDS Conference recommend.

The guidelines, formulated by the European AIDS Clinical Society, are intended to set a standard of care for the entire European region including Eastern Europe. The guidelines are revised every two years and updated in between as new evidence arises.

Among the other major additions and changes, European experts in HIV medicine now recommend:

  • Downgrading the use of atazanavir/ritonavir in first-line treatment owing to kidney toxicity
  • People with HIV should be considered for organ transplantation according to the same criteria as everyone else.
  • Doctors should consider screening for non-alcoholic fatty liver disease, especially in patients with metabolic syndrome, owing to the high prevalence of the condition in people with HIV.
  • Screening for chronic lung disease should become standard practice in smokers and people over the age of 40.
  • HPV vaccination is now recommended for all people with HIV under 26 and all MSM up to the age of 40.

The full guidelines document is available to download from the EACS website or as an app. The guidelines also include links to video tutorials on aspects of diagnosis and consultation.